These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33886091)

  • 1. Abnormal nuclear envelope in the cerebellar Purkinje cells and impaired motor learning in DYT11 myoclonus-dystonia mouse models.
    Yokoi F; Dang MT; Yang G; Li J; Doroodchi A; Zhou T; Li Y
    Behav Brain Res; 2012 Feb; 227(1):12-20. PubMed ID: 22040906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype.
    Peall KJ; Kurian MA; Wardle M; Waite AJ; Hedderly T; Lin JP; Smith M; Whone A; Pall H; White C; Lux A; Jardine PE; Lynch B; Kirov G; O'Riordan S; Samuel M; Lynch T; King MD; Chinnery PF; Warner TT; Blake DJ; Owen MJ; Morris HR
    J Neurol; 2014 Dec; 261(12):2296-304. PubMed ID: 25209853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case Report of Myoclonus-Dystonia with Isolated Myoclonus Phenotype and Novel Mutation Successfully Treated with Deep Brain Stimulation.
    Besa Lehmann V; Rosenbaum M; Bulman DE; Read T; Verhagen Metman L
    Neurol Ther; 2020 Jun; 9(1):187-191. PubMed ID: 32274660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of proteasome activity promotes the correct localization of disease-causing alpha-sarcoglycan mutants in HEK-293 cells constitutively expressing beta-, gamma-, and delta-sarcoglycan.
    Gastaldello S; D'Angelo S; Franzoso S; Fanin M; Angelini C; Betto R; Sandonà D
    Am J Pathol; 2008 Jul; 173(1):170-81. PubMed ID: 18535179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sporadic and familial myoclonic dystonia: Report of three cases and review of literature.
    Bhattacharyya KB; Roy A; Biswas A; Pal A
    Ann Indian Acad Neurol; 2016; 19(2):258-60. PubMed ID: 27293342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translating Genetic Discovery into a Mechanistic Understanding of Pediatric Movement Disorders: Lessons from Genetic Dystonias and Related Disorders.
    Lin WS
    Adv Genet (Hoboken); 2023 Jun; 4(2):2200018. PubMed ID: 37288166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms underlying phenotypic variation in neurogenetic disorders.
    Burgunder JM
    Nat Rev Neurol; 2023 Jun; 19(6):363-370. PubMed ID: 37202496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extension of the DNAJB2a isoform in a dominant neuromyopathy family.
    Sarparanta J; Jonson PH; Reimann J; Vihola A; Luque H; Penttilä S; Johari M; Savarese M; Hackman P; Kornblum C; Udd B
    Hum Mol Genet; 2023 Oct; 32(21):3029-3039. PubMed ID: 37070754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dystonia Responding to Levodopa in A Child with Myoclonus-Dystonia.
    Chang V; Mingbunjerdsuk D
    Mov Disord Clin Pract; 2023 Apr; 10(4):687-690. PubMed ID: 37070063
    [No Abstract]   [Full Text] [Related]  

  • 10. Benchmarking post-GWAS analysis tools in major depression: Challenges and implications.
    Pérez-Granado J; Piñero J; Furlong LI
    Front Genet; 2022; 13():1006903. PubMed ID: 36276939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of major and brain-specific Sgce isoforms in the pathogenesis of myoclonus-dystonia syndrome.
    Xiao J; Vemula SR; Xue Y; Khan MM; Carlisle FA; Waite AJ; Blake DJ; Dragatsis I; Zhao Y; LeDoux MS
    Neurobiol Dis; 2017 Feb; 98():52-65. PubMed ID: 27890709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and genetic analysis of childhood-onset myoclonus dystonia syndrome caused by SGCE variants].
    Tian XJ; Ding CH; Zhang YH; Dai LF; Chen CH; Li JW; Wang X; Han TL; Wang XH; Deng J
    Zhonghua Er Ke Za Zhi; 2020 Feb; 58(2):123-128. PubMed ID: 32102149
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic Aspects of Myoclonus-Dystonia Syndrome (MDS).
    Rachad L; El Kadmiri N; Slassi I; El Otmani H; Nadifi S
    Mol Neurobiol; 2017 Mar; 54(2):939-942. PubMed ID: 26790671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ε-Sarcoglycan: Unraveling the Myoclonus-Dystonia Gene.
    Cazurro-Gutiérrez A; Marcé-Grau A; Correa-Vela M; Salazar A; Vanegas MI; Macaya A; Bayés À; Pérez-Dueñas B
    Mol Neurobiol; 2021 Aug; 58(8):3938-3952. PubMed ID: 33886091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SGCE missense mutations that cause myoclonus-dystonia syndrome impair epsilon-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsinA.
    Esapa CT; Waite A; Locke M; Benson MA; Kraus M; McIlhinney RA; Sillitoe RV; Beesley PW; Blake DJ
    Hum Mol Genet; 2007 Feb; 16(3):327-42. PubMed ID: 17200151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty years on: Myoclonus-dystonia and ε-sarcoglycan - neurodevelopment, channel, and signaling dysfunction.
    Menozzi E; Balint B; Latorre A; Valente EM; Rothwell JC; Bhatia KP
    Mov Disord; 2019 Nov; 34(11):1588-1601. PubMed ID: 31449710
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.